Funded Tech Companies
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals, operating out of Lexington, has financial backing from SR One Capital Management, Deerfield Capital and Brookside Capital.
Company Overview
Company Name
Dicerna Pharmaceuticals
Company Status
Publicly-held
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
33 Hayden Ave.
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Company Background Information
Overview
Dicerna (NASDAQ: DRNA) is working to improve the lives of people suffering from rare diseases, chronic liver diseases, cardiovascular disease, and viral liver infectious diseases. We discover and develop innovative therapies to stop or turn off destructive disease processes by silencing the genes underlying these processes.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
1/30/2014
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Douglas Fambrough
Chief Financial Officer
Jack Green
Chief Medical Officer
Ralf Rosskamp
Chief Scientific Officer
Bob Brown
Vice President
Jennifer Lockridge
VP - Bus. Development
James Weissman
VP - Operations
David Miller
Company Investors
- SR One Capital Management
- Deerfield Capital
- Brookside Capital
- Omega Funds
- Domain Associates (Brian Halak)
- Skyline Ventures (Stephen Hoffman)
- Abingworth (Vincent Miles)
- RA Capital (Peter Kolchinsky)
- Oxford Bioscience Partners (Jonathan Fleming)
- SR One Capital Management (Brian Gallagher)
- Oxford Bioscience Partners (Douglas Fambrough)
Browse more funded tech companies:
DiCentral | Dick's Sporting Goods
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a market leader in private equity transaction data.
Additional Resources for Entrepreneurs